Although Quest Diagnostics Inc (DGX) is up over 9.3% in the past four weeks, investors may be concerned. After all, DGX is now in overbought territory, at least when looking at its RSI value of 73.2. If that wasn’t enough, investors should also note that Quest Diagnostics possesses a Zacks Rank #4 (Sell), so if analyst perception is any guide, we could witness a slump in DGX shares before too long.
QUEST DIAGNOSTICS INC (DGX): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Investment & Company Information
- Quest Diagnostics